Crystal Genomics identified that 'Polmacoxib' has effect for preventing and curing colon cancer

Published: 2014-08-12 09:12:13

Updated: 2014-08-12 09:12:13

New drug development bio-venture company, Crystal Genomics identified that their new degenerative arthritis treatment 'Polmacoxib' of which they applied new drug application (NDA) in May, has effect for preventing and curing colon cancer.

The result of study was published in the August 3 issue of 'Investigational New Drugs' which is a professional pharmaceutical journal of the United States.

...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.